ArticleClinical epidemiology2026
Development and External Validation of Machine Learning Model to Predict Live Birth Following Assisted Reproductive Technology in Women with Ovarian Endometriomas: A Decision-Support Tool.
Article in Clinical epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ovarian endometriomas damage the ovarian structure, alter ovarian inflammation, and impair ovarian reserve. Given the conflicting results, determining an optimal reproductive strategy for women with endometriomas-whether expectant management, medication, surgery, or assisted reproductive technology (ART)-remains challenging. Objective: This study aims to preliminarily develop and validate clinically applicable decision-support tools by training, testing, and validating an automated machine learning (ML) model to predict the likelihood of live birth following ART in women with endometriomas. Methods: The derivation and testing cohort included 1705 women, and the external validation cohort included 1475 women with ovarian endometriomas following ART retrospectively. Two ML models were developed and validated to predict the probability of live birth. Model performance was evaluated using the area under the curve (AUC), accuracy, sensitivity, specificity, F1 score, and Brier score. The SHapley Additive exPlanations (SHAP) method was employed to interpret feature importance. Results: Comparing seven ML algorithms, the Extreme Gradient Boosting (XGBoost) demonstrated superior predictive performance both in model-1 and model-2, achieving an AUC of 0.90 [95% confidence interval (CI): 0.88-0.92] and 0.88 (95% CI: 0.86-0.89) in test-datasets and 0.80 (95% CI: 0.76-0.83) and 0.69 (95% CI: 0.65-0.73) in external validation cohort. The SHAP analysis revealed that the age and features associated with ovarian reserve had strong predictive power and the ovarian endometriomas had limited predictive power. Conclusion: Model-2, which uses only pre-ART variables, can support reproductive strategy selection prior to ART initiation. Conversely, Model-1 is designed to support embryo transfer strategy option after oocyte retrieval, incorporating post-ART data. Although both models show promise as decision-support tools for personalizing infertility treatment in women with endometriomas, their clinical implementation awaits confirmation from prospective, multicenter validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.